pharma · Pulmonary Arterial Hypertension · Iron Deficiency Anemia · KROS
Keros Therapeutics
Keros Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Cambridge, USA HQ
2021 Founded
10 Employees
Public company Type
KROS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2021
- Employees
- 10
- Programs
- 3
- Drugs
- 2
- Patents
- 12
Keros Therapeutics clinical trials
Registry index of 3 ClinicalTrials.gov studies linked to Keros Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Keros Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Keros Therapeutics.